Vascular risk factors affect different brain regions in people with Alzheimer’s disease

por Tripathi, S., Murray, A., Wischik, C., Schelter, B.
Publicado 2022

Oral Tau Aggregation Inhibitor for Alzheimer’s Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydrome...

por Wischik, Claude M., Bentham, P., Gauthier, S., Miller, S., Kook, K., Schelter, B. O.
Publicado 2022